THISFORMMUSTBE IN ENGLISH AND RETURNED BEFOREORIENTATIONTO: ­­ ­­ ­­ ­­ ­­ State­­ ­­ ­­ ­­ ­­ ­­ ­­ ­­ ­­ ­­ ­­SSN/Student­­ID­­#­­ ­­ ­­ ­­ ­­ ­­­­­­­­ ­­ ­­ ­­ Zip­­Code Email­­­­ ­­ ­­ ­­ ­­ ­­Date­­of­­Birth­­ ­­­­­­­­­­­­­­/­­­­­­­­­­­­­­/­­ ­­­­­­­­ ­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­Mo­­­­­­­­­­­­­­Day­­­­­­­­­­­­­­Yr­­­­­­­­­­­­­­ ­­Age at time entering University BBB ­­ SEX: M ____ F ____ ­­ ­­ ­­ ­­ ­­ Applying­­for:­­­­­­­­☐­­Fall­­­­­­­­☐­­­­Spring­­­­­­­­☐­­­­Summer­­I­­­­­­­­☐­­­­Summer­­II­­­­­­­­☐­­­­Maymester­­­­­­­­Year­­­­ Check­­one:­­­­­­­­­­­­☐­­Undergraduate­­­­­­­­­­☐­­­­Graduate­­­­­­­­☐­­­­Other ­­ ­­ ­­ ­­ ­­ ­­ ­­ ­­ ­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­Middle­­ ­­ ­­ ­­ ­­ ­­ ­­ ­­ ­­ ­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­Mo­­­­­­­­­­­­­­­­Day­­­­­­­­­­­­­­­­­­Yr­­­­ ­­ ­­ ­­ ­­ ­­ ­­ ­­ ­­ ­­­­­­­­Middle ­­☐­­Dose 2 give at least 28 days after the first dose….....................................................­­#2­­­­­­­­­­­­­­/­­­­­­­­­­­­­­­­­­/­­­­ ­­ ­­­­Mo­­­­­­­­­­­­­­­­Day­­­­­­­­­­­­­­­­­­­­Yr­­­­­­ ­­ ­­ ­­ ­­ ­­­­­­­­­­­­­­ ­­ ­­ M.M.R.(Measles,Mumps,Rubella)­­[Two­­doses­­required­­for­­students­­born­­in­­1957­­or­­later] a.­­☐ Dose­­1­­given­­at­­age­­12­­months­­or­­later­­………………….……..……………………......#1­­­­­­­­­­­­­­/­­­­­­­­­­­­­­­­­­/­­ ­­ RequiredImmunizationsForALLStudentsMustBeCompleted&SignedByYourHealthcareProvider (or attach a legible photocopy verified by a doctor’s signature or stamp or by a clinic or health department stamp) ­­­­ ­­ ­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­First­­ ­­ ­­­­­­­­­­­­­­City­­­­ ­­ Telephone­­(­­­­­­­­­­­­­­­­­­­­)­­ ­­ ­­ ­­ ­­ ­­­­­­ ­­ ­­ ­­ ­­First­­ ­­ ­­ Name­­­­­­­­­­­­­­ ­­ ­­ ­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­Last­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­ Address­­­­­­ ­­ ­­ ­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­ Street/P.O.­­Box­­ ­­ ImmunizationCoordinator,Box35 UniversityofSouthCarolinaAiken 471UniversityParkway Aiken,SC29801 Ph:(803)641-3487,Fax:(803)641-3727 ­­ TOBECOMPLETEDBYSTUDENT Last­­ Student­­Name­­ ­­ ­­ ­­ ­­OR­­­­­­­­­­ ­­b.­­☐ Laboratory/serologic evidence of immunity (attach a copy of a positive titer with the date of the titer) ­­­­­­­­­­­­­­­­­­ ­­­­­­­­ c.­­☐ Exemption:­­I­­was­­born­­before­­1957,­­and­­therefore­­am­­exempt­­from­­this­­requirement ReviewFactsonMeningococcalDisease(seepage2)beforemakingadecisiononreceivingtheMenactraImmunization/Vaccine (Menactra­­must­­be­­dated­­after­­2005) a.☐ Option1:­­I received Menactra (MCV4) Vaccine at my healthcare provider’s office (pediatrician’s office, health department, or clinic). ­­­­*BottomSection(HealthCareProvider)MustBeCompleted&Signed­­by­­your­­vaccine­­provider;­­OR­­A­­Legal­­Photocopy­­of­­your­­Student’s­­Immunization/ Vaccine Records may be attached as long as it is verified with a doctor’s signature or stamp, or by a clinic or health department’s stamp. AdministrationDate­­­­­­­­­­­­­­/­­­­­­­­­­­­­­­­­­/­­ Menactra(MCV4)VaccineLot#­­­­ ­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­Mo­­­­­­­­­­­­­­Day­­­­­­­­­­­­­­­­­­Yr­­­­ b.☐ Option2:­­­­IwouldliketoreceiveMenactra(MCV4)VaccineintheUSCAStudentHealthCenterduringFreshmanOrientation. Please­­provide­­a­­phone­­number­­&­­email­­where­­you­­can­­best­­be­­reached:­­Ph­­(­­ ) ­­­­ ­­­­­­­­­­­­ ­­Email­­ ­­ ­­ ­­ SSN/Student­­Number RequiredImmunizationsForFreshmanStudentsLivinginHousing c.☐ Option3:Ihavereadtheinformationprovidedonpage2&educatedmyselfontherisksofMeningococcalDisease. IchooseNOTtobevaccinatedwithMenactra(MCV4). Signature(parent­­signs­­if­­student­­is­­under­­18­­years­­of­­age) ­­Date: *HealthCareProvider­­­­Signature­­or­­Stamp­­Required­­from­­all­­students­­receiving­­MMR­­and­­those­­in­­housing­­receiving­­Menactra Name:­­ ­­ ­­ ­­ ­­ ­­ ­­ _______Date:­­­­ ­­ ­­ ­­ ­­ ­­ Address:­­­­ ­­ ­­ ­­ ­­ ­­ ­­ ­­ ­­ ­­ ­­ ­­ ­­ ­­ ­­ ­­ ­­ ­­ ­­ ­­ ­­ ­­ ­­ ­­ ­­ ­­ ­­­­­­)­­ ­­ ­­ ­­ ­­ ­­Signature:­­­­ ­­ ­­ ­­ ­­ ­­ ­­ ­­ ­­ (Please­­Print) ­­­­­­­­­­­­­­Street/P.O.­­Box ­­ ­­ Phone:­­(­­ City­­ ­­ ­­ ­­ State­­ ­­ ­­ ­­ ­­ Zip­­Code­­ See reverse side for additional immunization required for international students and recommended immunizations for all students Revised­­7/10 **AdditionalImmunizationRequiredforInternationalStudents** TuberculosisScreening 1.­­Have­­you­­ever­­had­­a­­positive­­TB­­skin­­test?..................................................YES­­________­­NO­­________ 2.­­Have­­you­­ever­­had­­close­­contact­­with­­anyone­­who­­was­­sick­­with­­TB?.........YES­­________­­NO­­________ 3.­­Have­­you­­ever­­been­­vaccinated­­with­­BCG?..................................................YES­­________­­NO­­________ 4.­­Are­­you­­are­­a­­member­­of­­a­­high-risk­­group¹?................................................YES­­________­­NO­­________ 5.­­If­­No­­(to­­#4),­­you­­are­­not­­required­­to­­have­­a­­TB­­screening.­­If­­YES,­­you­­are­­required­­to­­have­­a­­TB­­screening. ­­­­­­­­BCG­­vaccine­­is­­not­­acceptable­­to­­meet­­this­­requirement. ­­­­­­­­1.­­­­TuberculinSkinTest: Date­­Given:­­­­­­­­­­­­/­­­­­­ ­­­­­­­­­­/­­­­­­­­­­ ­­­­­­­­­­ ­­ ­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­Mo­­­­­­­­­­­­­­­­­­Day­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­Yr­­­­­­ ­­ ­­­­­­­­­­­­Result:­­ ­­­­­­­­­­­­Positive­­ ­­ ­­ ­­ Date­­Read:­­­­­­­­­­­­­­­­­­/­­­­­­ ­­ ­­­­­­­­­­/­­­­­­­­­­ ­­­­­­­­­­ ­­­­­­­­­­­­­­­­­­­­­­­­Mo­­­­­­­­­­­­­­­­­­­­­­­­­­Day­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­Yr­­­­ ­­mm­­(Record­­actual­­mm­­of­­induration,­­transverse­­diameter;­­if­­no­­induration,­­write­­“0”) ­­Negative­­ ­­­­(Interpretation,­­based­­on­­mm­­of­­induration­­as­­well­­as­­risk­­factors) ­­­­­­­­­­2.­­­­ChestX-ray(required­­if­­tuberculin­­skin­­test­­is­­positive) ­­­­­­­­­­­­Date­­of­­chest­­x-ray­­­­­­­­­­­­/­­­­­­ ­­­­­­­­­­/­­­­­­­­­­ ­­­­­­­­­­ Normal­­­­ ­­­­_______­­­­Abnormal­­­­ ­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­Mo­­­­­­­­­­­­­­Day­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­Yr­­­­­­ ­­ ­­­­­­­­­­Chest­­X-ray­­Findings­­(if­­abnormal)____________________________________________ ¹­­Categories­­of­­high­­risk­­students­­include­­those­­students­­who­­have­­arrived­­within­­the­­past­­5­­years­­from­­countries­­where­­TB­­is­­endemic.­­­­It­­is­­easier­­to­­identify­­countries­­of­­low­­rather­­than­­high­­TB­­prevalence.­­­­Therefore,­­students­­should­­undergo­­ TB­­screening­­if­­they­­have­­arrived­­from­­countries­­EXCEPT­­those­­on­­the­­following­­list:­­­­Canada,­­Jamaica,­­Saint­­Kitts­­and­­Nevis,­­Saint­­Lucia,­­USA­­Virgin­­Islands­­(USA),­­Belgium,­­Denmark,­­Finland,­­France,­­Germany,­­Greece,­­Iceland,­­Ireland,­­Italy,­­ Liechtenstein,­­Luxembourg,­­Malta,­­Monaco,­­Netherlands,­­Norway,­­San­­Marino,­­Sweden,­­Switzerland,­­United­­Kingdom,­­American­­Samoa,­­Australia­­or­­New­­Zealand.­­­­ RecommendedImmunizationsforAllStudents Although­­they­­are­­not­­yet­­required,­­meningococcaland­­hepatitisB­­vaccinations­­are­­stronglyrecommendedbased­­on­­ recommendations­­from­­the­­Centers­­for­­Disease­­Control­­(CDC)­­and­­the­­American­­College­­Health­­Association.­­­­These­­recommendations­­ are­­made­­based­­on­­recent­­studies­­showing­­that­­college­­students,­­particularly­­freshmen­­living­­in­­residence­­halls,­­have­­a­­six-times­­ greater­­risk­­for­­meningitis­­and­­an­­increased­­risk­­of­­hepatitis­­B­­than­­the­­general­­population.­­­­ Meningococcaldiseaseis­­a­­rare­­but­­potentially­­fatal­­bacterial­­infection­­that­­occurs­­in­­one­­of­­two­­forms,­­either­­as­­meningococcal­­ Meningitis (a bacterial infection that causes inflammation of the brain and spinal cord) or meningococcemia (a bacterial infection of the blood). Meningitis is difficult to diagnose because of its flu-like symptoms. It progresses very quickly and may result in permanent disability or death within a matter of hours of the first symptoms. Transmission of the disease occurs from person to person through respiratory­­or­­oral­­secretions.­­­­Cases­­of­­meningitis­­among­­teens­­and­­young­­adults­­15­­to­­24­­years­­of­­age­­have­­more­­than­­doubled­­since­­ 1991.­­­­Ask­­about­­the­­Menactra­­vaccine­­for­­protection­­against­­Meningitis­­&­­Meningococcemia. HepatitisBvirus(HBV)­­exposure­­can­­result­­in­­a­­serious­­disease­­that­­attacks­­the­­liver.­­­­There­­is­­no­­cure­­for­­this­­disease.­­­­The­­CDC­­ estimates­­that­­some­­80,000­­new­­cases­­occur­­in­­the­­US­­each­­year­­and­­approximately­­500­­people­­die­­from­­chronic­­liver­­problems­­ related­­to­­hepatitis­­disease­­annually.­­­­HBV­­is­­a­­blood-borne­­disease­­and­­is­­commonly­­spread­­by­­contact­­with­­infected­­blood,­­needles­­or­­ other­­sharps,­­or­­by­­having­­sex­­with­­an­­infected­­person.­­­­The­­best­­protection­­against­­HBV­­is­­immunization.­­­­ In­­addition,­­it­­is­­recommended­­that­­students­­receive­­two­­varicella­­(chicken­­pox)­­vaccines­­if­­they­­have­­never­­had­­chicken­­pox­­or­­receive­­ a­­second­­varicella­­vaccine­­if­­they­­have­­only­­received­­one­­previously.­­­­It­­is­­also­­recommended­­that­­female­­students­­receive­­the­­series­­of­­ three­­Gardasilvaccines­­to­­protect­­them­­from­­cervical­­cancer. For more detailed information, visit the Centers for Disease Control & Prevention web site at www.cdc.gov or the American College Health Association website at www.acha.org. Consult with your family physician, local Health Department and your Student Health Center for vaccine information. Revised­­7/10